Quest Diagnostics Balance Sheet Health
Financial Health criteria checks 3/6
Quest Diagnostics has a total shareholder equity of $6.5B and total debt of $4.7B, which brings its debt-to-equity ratio to 72%. Its total assets and total liabilities are $14.0B and $7.4B respectively. Quest Diagnostics's EBIT is $1.3B making its interest coverage ratio 8.3. It has cash and short-term investments of $474.0M.
Key information
72.0%
Debt to equity ratio
US$4.71b
Debt
Interest coverage ratio | 8.3x |
Cash | US$474.00m |
Equity | US$6.55b |
Total liabilities | US$7.41b |
Total assets | US$13.95b |
Recent financial health updates
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Oct 06Recent updates
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04Quest Diagnostics declares $0.66 dividend
Nov 14Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 06Decode Health, Quest to collaborate to improve biomarker discovery for drug discovery
Oct 18Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Oct 06Quest Diagnostics to acquire select assets of Summa Health
Oct 05Quest Diagnostics: The Market Is Overlooking Long-Term Prospects
Sep 15Quest Diagnostics: Valuation Looks Good As Covid Testing Demand Tapers
Sep 09Returns Are Gaining Momentum At Quest Diagnostics (NYSE:DGX)
Aug 22Financial Position Analysis
Short Term Liabilities: DGX's short term assets ($2.2B) do not cover its short term liabilities ($2.3B).
Long Term Liabilities: DGX's short term assets ($2.2B) do not cover its long term liabilities ($5.1B).
Debt to Equity History and Analysis
Debt Level: DGX's net debt to equity ratio (64.7%) is considered high.
Reducing Debt: DGX's debt to equity ratio has reduced from 79% to 72% over the past 5 years.
Debt Coverage: DGX's debt is well covered by operating cash flow (28.3%).
Interest Coverage: DGX's interest payments on its debt are well covered by EBIT (8.3x coverage).